Crescendo Biologics

Home
About Us
Our Science
- Humabody^® V_H Platform
News & Events
- Press Releases
- Publications
Contact Us
LinkedIn
Twitter

Contact Us

Home
About Us
Our Science
- Humabody^® V_H Platform
News & Events
- Press Releases
- Publications

Home
About Us
Our Science
- Humabody^® V_H Platform
News & Events
- Press Releases
- Publications
Contact Us
LinkedIn
Twitter

Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

Post navigation

Previous PostPrevious Crescendo Biologics’ second oncology-targeted Humabody® licensed by Takeda

Next PostNext Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey

Search for:

Recent Posts

Crescendo Biologics enters pre-clinical collaboration with Orano Med to explore Targeted Alpha Therapy
Hello world!
Clinical Development
Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic
Chief Medical Officer

Recent Comments

Archives

July 2020
May 2020
February 2020
January 2020
October 2019
September 2019
July 2019

Categories

Front Page
In the News
PR & News
Uncategorised
Videos

Meta

Log in
Entries feed
Comments feed
WordPress.org

Humabody^® and Multibody^® are registered trademarks of Crescendo Biologics Limited.
Privacy and Cookies Notice Cambridge Web Design

We use cookies to give you a better experience on our website. To find out more, and to manage your preferences, please consult our Privacy and Cookie Notice.